Cartalax Australia: Buy Cartalax Online

Shop Cartalax Peptide as a 20 mg Vial With Lot Data and Identity

Name	Cartalax (AED)
Sizes and prices (AUD)	20 mg vial at $69
Sequence or structure	Ala-Glu-Asp, linear tripeptide (H-Ala-Glu-Asp-OH)
Length	3 amino acids
Molecular formula	C12H19N3O8
Molar mass	333.3 g/mol
Form	Lyophilised white powder in a sealed glass vial
Testing	Mass confirmed by mass spectrometry, purity measured by HPLC, certificate issued for each lot
Contents	One 20 mg vial of Cartalax per unit, shipped dry, with diluent as a separate purchase
Storage	Sealed at -20 °C in the dark. Dissolved at 2 to 8 °C in aliquots
Availability	In stock
Use	Laboratory in vitro research only

Order Cartalax for connective tissue and cell ageing studies in a generous 20 mg fill, twice the size of most bioregulator vials. It is in stock in Australia, each batch is certified, and one vial carries a long culture series.

What Is Cartalax Peptide?

Cartalax is a synthetic peptide made of just three amino acids that is studied for its effect on ageing connective tissue cells, the cells that build and maintain cartilage, skin and other structural tissue. In the papers it is usually written by its one-letter code, AED.

The idea behind a cartilage bioregulator

The St Petersburg school that produced Cartalax works from one central claim: that a tissue's own short peptide fragments help keep its genes running in a youthful pattern, and that a synthetic copy can restore some of that pattern in older cells. Each sequence in the family was matched to an organ. AED was assigned to cartilage and the wider group of connective tissues. No receptor has been found for it. The developers propose that the tripeptide reaches the nucleus and interacts with chromatin, a model that remains unproven outside their own laboratories.

What the cell studies measured

The clearest published dataset is in skin fibroblasts rather than cartilage. A 2016 paper in the Bulletin of Experimental Biology and Medicine (Lin'kova and colleagues) aged fibroblast cultures through repeated passages and then compared four short peptides, AED among them, using confocal microscopy. Four markers were tracked:

• Ki-67, a protein present only in dividing cells, so a rough gauge of proliferation
• CD98hc, a membrane transporter subunit that falls as fibroblasts age
• MMP-9, an enzyme that breaks down extracellular matrix and rises with culture age
• caspase-3, the executioner enzyme of programmed cell death

All four peptides lowered MMP-9 and raised Ki-67 and CD98hc, while AED and the four-residue AEDG also damped caspase-dependent apoptosis. A follow-up in the same journal in 2020 compared AED with the dipeptide KE in replicatively aged skin fibroblasts. Chondrocyte work exists too, though much of it appears in Russian-language sources that are harder to check.

The practical point we would stress: every effect above was reported in old cultures, not young ones. A lab testing AED should run matched early-passage and late-passage cells from the same donor line side by side. If the peptide shifts Ki-67 or MMP-9 only in the late-passage plates, that is consistent with the published picture. If it shifts both equally, something other than an ageing-specific effect is at work, and you have learned that cheaply from a single vial.

Buy Cartalax Peptide Online in Australia, the AED Cartilage Bioregulator

Cartalax belongs to the family of short peptides developed at Vladimir Khavinson's institute in St Petersburg, where each tiny sequence was paired with a tissue of interest. Cartalax, as its name hints, is the one assigned to cartilage. Its three residues, alanine, glutamic acid and aspartic acid, make it one of the lightest compounds we sell.

Order it knowing where the literature stands. Most published work comes from Khavinson's group and collaborators and sits in cell culture, with chondrocytes from older donors or heavily passaged cultures, skin fibroblasts carrying senescence markers, and expression of matrix genes such as collagens. The proposed mechanism, that short peptides act on chromatin to switch tissue-specific genes, is still a hypothesis with limited independent replication, and that open status is what makes it worth testing with defined material. Shop it in our longevity peptides and recovery peptides ranges, where it is listed as a research reagent rather than a medicine. That dual listing reflects how labs use it, since connective tissue ageing panels can test it against longer repair peptides without changing their culture system.

Buying Cartalax in Australia: The 20 mg Vial and Its Regulatory Position

A Cartalax order brings one glass vial with a white cap and a pink and blue label, holding 20 mg of AED as a dry white cake. That fill is double the 10 mg common to Pinealon and other bioregulator vials, which suits labs that keep a concentrated master stock. Only the peptide's sequence links it to Russia: the AED chain was described within Vladimir Khavinson's short peptide programme at the St Petersburg Institute of Bioregulation and Gerontology, a body he founded in 1992 after years running the bioregulator laboratory at the Kirov Military Medical Academy. Most of what has been published about the tripeptide still comes from that group and its collaborators, so the evidence base is narrow and almost entirely in cultured cells.

Is Cartalax legal in Australia? The compound is not listed by name in the Poisons Standard as of October 2026, and our check of the October 2026 instrument found no entry for AED or Ala-Glu-Asp, so no schedule applies to it as a named substance. An unscheduled peptide is still not a therapeutic good. Supplying any peptide for therapeutic use requires inclusion on the Australian Register of Therapeutic Goods, and the TGA has said unapproved peptide products are a compliance focus. That framework explains why Cartalax Australia buyers find it through reagent catalogues rather than through medical supply chains.

Cartalax for sale at AminoBlend is held in Australian stock and supplied only as a research reagent for laboratory use. Orders are accepted from adults 18 and over, and the vial is not for human or veterinary use under any circumstances. Labs planning a wider connective tissue comparison can read the terms of supply on our research use policy page before ordering.

Order Cartalax for Sale in a 20 mg Vial With Lot Tracking

Cartalax comes in one size, a 20 mg vial at $69, or about $3.45 per milligram. At roughly 333 g/mol, that vial holds around 60 micromoles of AED, enough for many plates of chondrocyte or fibroblast culture before a second vial is needed. The larger fill also suits labs that prefer a concentrated master stock, since the extra powder lets you prepare one strong solution and dilute working aliquots from it without opening another vial.

Buy every vial up front when a study will run for months, so they ship from the same lot wherever stock allows under one certificate and no batch change interrupts the series. Cartalax is sold strictly to adults aged 18 and over.

Buy Cartalax Peptide With Structure, Purity and Lot Certificate Verified

AED carries two acidic side chains and a free C-terminal acid, which makes it very polar and easy to dissolve. Its small size is also its analytical weak point, because a tripeptide of similar composition could resemble it on HPLC alone, so mass confirmation is what fixes identity. If you run your own LC-MS check on arrival, the singly protonated ion should appear close to 334 on the mass-to-charge scale.

Shop with the certificate open and check that the measured mass agrees with 333.3 g/mol, that the chromatogram shows one main peak, and that the reported purity applies to your lot number. Certificates are kept in the COA library, indexed by the lot printed on each label, and our guide on how to read a COA walks through every line of one.

Order Cartalax Online for Delivery Near You and Store the Vial

Cartalax is not sold over any counter. AminoBlend is an online store that ships across Australia from local stock, and payment received before 3pm on a business day means dispatch that same day. See delivery information for transit times by region, including for labs buying research peptides in Perth.

Warm the sealed vial to room temperature, add diluent slowly down the side of the glass and swirl gently until clear. With 4 mL of bacteriostatic water the 20 mg vial gives 5 mg/mL, and 2 mL gives a stronger 10 mg/mL stock, while the peptide calculator covers every other volume.

Unopened, the vial stays at -20 °C away from moisture and light. Once in solution, keep it at 2 to 8 °C and split it into single-use portions so the stock is not cycled between temperatures. Write the date and concentration on every tube, because months later that note is what ties an aliquot to its certificate.

Other Names for Cartalax

Cartalax is also written as AED, Ala-Glu-Asp, H-Ala-Glu-Asp-OH or L-alanyl-L-glutamyl-L-aspartic acid. Russian literature places it among the peptide bioregulators, sometimes described as cytogens, and links it to cartilage and connective tissue. All of these names describe the same 333.3 g/mol tripeptide with the formula C12H19N3O8. Some catalogues print it simply as AED peptide or as a cartilage bioregulator, with no change in the molecule supplied.

Order Cartalax or Epitalon to Test a Single Residue

Epitalon reads Ala-Glu-Asp-Gly, so Cartalax is the same chain minus its final glycine. Despite that near identity, the two are studied in different cells, Epitalon in telomerase and pineal ageing models and Cartalax in chondrocytes and fibroblasts. Order Cartalax for matrix and cartilage endpoints, Epitalon for telomerase questions, and both when you want to know whether one extra residue changes the result. Because the two differ only at the C-terminus, any gap between their readouts points directly at that glycine.

Shop BPC-157 as a contrast when comparing tissue-repair tools. It is a 15-residue gastric peptide fragment with a broad soft tissue literature, unrelated to Cartalax in structure and proposed mechanism.